Neovascular macular degeneration: a review of etiology, risk factors, and recent advances in research and therapy

A Pugazhendhi, M Hubbell, P Jairam… - International Journal of …, 2021 - mdpi.com
Neovascular age-related macular degeneration (exudative or wet AMD) is a prevalent,
progressive retinal degenerative macular disease that is characterized by …

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and …

Y Inamoto, N Valdés-Sanz, Y Ogawa, M Alves… - Bone marrow …, 2019 - nature.com
Ocular graft-versus-host disease (GVHD) occurs in more than half of patients who develop
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …

Brolucizumab in neovascular age-related macular degeneration–Indian real-world experience: the BRAILLE study

D Chakraborty, A Maiti, JU Sheth, S Boral… - Clinical …, 2021 - Taylor & Francis
Purpose To assess the short-term efficacy and safety profile of intravitreal brolucizumab
injection in Indian eyes with neovascular age-related macular degeneration (nAMD) under …

The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases

L Ferro Desideri, CE Traverso… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Several approaches have been investigated for treating wet age-related
macular degeneration (w-AMD), diabetic macular edema (DME) and retinal vein occlusions …

Automated detection of a nonperfusion area caused by retinal vein occlusion in optical coherence tomography angiography images using deep learning

D Nagasato, H Tabuchi, H Masumoto, H Enno… - PloS one, 2019 - journals.plos.org
We aimed to assess the ability of deep learning (DL) and support vector machine (SVM) to
detect a nonperfusion area (NPA) caused by retinal vein occlusion (RVO) with optical …

Changing trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: insights from the Vitreoretinal Society of India Biosimilars of Anti-VEGF …

JU Sheth, MW Stewart, M Khatri, SR Gupta… - Indian Journal of …, 2021 - journals.lww.com
Purpose: The aim of this study was to present the outcomes of the 2018 and 2020 Vitreo-
retinal Society of India (VRSI) biosimilars of anti-vascular endothelial growth factor …

[HTML][HTML] Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: a real-world case series

D Chakraborty, JU Sheth, S Boral, TK Sinha - American Journal of …, 2021 - Elsevier
Purpose To report the efficacy of intravitreal injection (IVI) of brolucizumab for recalcitrant
diabetic macular edema (DME) in a real-world setting. Observations This was a single …

Imaging features of vessels and leakage patterns predict extended interval aflibercept dosing using ultra-widefield angiography in retinal vascular disease: findings …

A Moosavi, N Figueiredo, P Prasanna… - IEEE Transactions …, 2020 - ieeexplore.ieee.org
Diabetic Macular Edema (DME) and macular edema secondary to retinal occlusion (RVO)
are the two most common retinal vascular causes of visual impairment and leading cause of …

Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin‐1

T Kida - BioMed research international, 2017 - Wiley Online Library
Retinal vein occlusion (RVO) is a common vascular disease of retina; however, the
pathomechanism leading to RVO is not yet clear. In general, increasing age, hypertension …

Multi-compartment spatially-derived radiomics from optical coherence tomography predict anti-VEGF treatment durability in macular edema secondary to retinal …

SS Kar, DD Sevgi, V Dong… - IEEE Journal of …, 2021 - ieeexplore.ieee.org
Objective: Diabetic macular edema (DME) and retinal vein occlusion (RVO) are the leading
causes of visual impairments across the world. Vascular endothelial growth factor (VEGF) …